Daniel Ives at ARDD2026: A single-cell clock and perturbation-model reveals anti-fibrotic targets
Title history
- Daniel Ives at ARDD2026: A single-cell clock and perturbation-model reveals anti-fibrotic targets — observed on 20261105-1852 UTC (YouTube)
Keywords
Summary
185 words
Critical Evaluation
Value of the Information & Strength of the Argument
The value lies in the integration of a highly accurate single-cell aging clock with virtual cell perturbation models, enabling high-throughput target discovery that is validated in vitro. The argumentation is solid: the speaker systematically justifies each step—careful data quality, correlation with epigenetic clocks, validation with known interventions like mTOR, and corroboration with literature. The discovery that single genes can drive rejuvenation and anti-fibrotic effects is significant, though the presentation notes that some data are preliminary and targets are coded. The logic is coherent and builds from computational predictions to experimental confirmation, with appropriate caution about circularity and need for further validation. The talk also addresses practical barriers like delivery, showing a realistic perspective on translation.
Scientific Rigor, Source Quality, Title Accuracy
The scientific rigor is high: the study uses a large dataset, multiple validation approaches, and cross-references to published literature. Specific mention of Morgan Levine’s clock and the use of established pathways (TGF-beta, mTOR) adds credibility. However, key data are not yet peer-reviewed, and the code-naming of targets limits independent verification. The title accurately describes the content and the main finding. The description links provide context for the conference and organization, but no direct references to specific papers are given. Overall, the talk demonstrates a well-designed research program with appropriate caveats.
220 words
Title / Content Match
The title accurately reflects the content: a single-cell aging clock and perturbation model are used to identify anti-fibrotic targets for rejuvenation.
Quality & Reliability
7/10
The talk presents original research with detailed methodology, validation using epigenetic clocks, and references to known pathways. However, some data are not yet published and targets are code-named, limiting full scrutiny.
Key Moments
Markers derived by PSI from the transcript: the creator did not define chapters.
- Introduction: Daniel Ives introduces Shift Bioscience and the goal of finding new genes for epigenetic reprogramming.
- Description of building a single-cell aging clock using primary dermal fibroblasts, methylome and transcriptome data.
- Introduction to virtual cells and excitement about SCGPT; the 'dance of the black boxes' concept.
- Perturbation results: discovery of single genes that drive rejuvenation, including knockdown effects.
- Overexpression screen highlights SP101 in the TGF-beta pathway; dual knockdown screen for age and fibrosis.
- Validation of gene 101 with epigenetic clocks (principal component clock from Morgan Levine) and dose-dependent rejuvenation.
- Multi-tissue testing in liver, lung, and heart fibroblasts showing anti-fibrotic effects.
- Delivery challenges, especially to hepatic stellate cells; mention of clinical precedent and other hits.
Cited Sources
- Aging Pharma - Official Website — Conference website for ARDD, providing context for the talk.
- Aging Pharma on LinkedIn — LinkedIn page for the conference, mentioned in the description.
Contribution & Novelties
The original contribution is the combination of a highly accurate single-cell aging clock with virtual cell perturbation models to systematically identify single genes capable of inducing rejuvenation and anti-fibrotic effects. Notably, the finding that knockdown of a single gene (SP101) can reverse aging and fibrosis across multiple tissue types is novel. The dual screening approach (age and fibrosis) provides a practical framework for discovering targets with dual benefits, and the integration of computational and wet-lab validation speeds up target identification.
Pour aller plus loin :
- Yamanaka factors — Foundational work on cellular reprogramming, context for rejuvenation strategies.
- Epigenetic clock — Background on DNA methylation-based aging measures used in the talk.
- TGF-beta signaling pathway — Canonical pathway involved in fibrosis and the target of SP101.
- SCGPT (single-cell foundation model) — Mentioned in the talk as inspiration; no reliable URL known, but relevant to virtual cell technology.
145 words
Radar Profile
The radar profile shows high technical depth and good information quantity, with slightly lower scores in quality and reliability due to the preliminary nature of the data and lack of full publication. Overall, the talk is technically strong and credible, with room for further validation.